跳至主要内容
临床试验/NCT05452031
NCT05452031招募中不适用

A Dyadic Approach to Improve Sleep and Well-Being Among Persons With Alzheimer's Disease and Their Caregivers

University of California, Los Angeles6 个研究点 分布在 1 个国家目标入组 672 人开始时间: 2022年11月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
672
试验地点
6
主要终点
Pittsburgh Sleep Quality Index score

研究概览

简要总结

This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation (for caregivers only). Eligible participants will be randomly assigned to in-person Care2Sleep, telehealth Care2Sleep, or to an in-person education control group. The Care2Sleep programs and the control education program will consist of five sessions. The intervention and control programs will begin after baseline assessment and randomization. Posttreatment assessments will be performed immediately after the last session and at 6-month follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • for Patients
  • Have a diagnosis of Alzheimer's disease (probable or possible) or other related dementia as documented in an electronic medical record
  • Community-dwelling
  • >1 sleep problems >3x/week on the Neuropsychiatric Inventory Nighttime Behavior Scale, - - Aged >60 years
  • Have no untreated sleep disorders (e.g., sleep apnea, restless legs syndrome)
  • Able to ambulate with or without assistive devices (i.e., dyads will be excluded if the care recipient is bedbound)
  • Have no severe medical conditions with a life expectancy of less than 6 months
  • Have an eligible caregiver
  • Inclusion Criteria for Caregivers
  • Live with an eligible patient
  • Aged >18 years
  • Is related to the patient as a family member, a significant other, or a friend
  • Have regularly assisted patient with >1 of 6 basic activities of daily living (ADLs; i.e., bathing, dressing, toileting, transferring, continence, feeding) or >1 of 8 Instrumental ADL (IADLs; i.e., using the telephone, shopping, food preparation, housekeeping, laundry, transportation, taking medications, managing money) for the past 6 months
  • Pittsburgh Sleep Quality Index (PSQI) total score >5
  • Montreal Cognitive Assessment (MoCA) ≥23
  • Can communicate in English

排除标准

  • Patients will be excluded if they are bedbound or have severe medical conditions with a life expectancy of less than 6 months.
  • Paid, professional caregivers will also be excluded.
  • If the eligibility criteria for either a patient or a caregiver are not met, the dyads will be excluded for this study.

研究组 & 干预措施

In-Person Care2Sleep

Experimental

In-person, manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy

干预措施: Care2Sleep (Behavioral)

Telehealth Care2Sleep

Active Comparator

Telehealth, manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy

干预措施: Care2Sleep (Behavioral)

Sleep Education only

Placebo Comparator

In-person, education on sleep, aging, and dementia but without specific or individualized recommendations

干预措施: Sleep Education (Behavioral)

结局指标

主要结局

Pittsburgh Sleep Quality Index score

时间窗: Change from Baseline Pittsburgh Sleep Quality Index score at 6 months

Self-reported sleep quality over the past week for patients (reported by caregivers) and caregivers. Range from 0 to 21 with lower scores indicating better subjective sleep quality.

Sleep efficiency-Actigraphy

时间窗: Change from Baseline Sleep Efficiency at 6 months

Nighttime sleep efficiency (i.e., mean percent of time in bed spent asleep) will be calculated from 7 days of wrist actigraphy for patients and caregivers. Range from 0 to 100% with a higher percent indicating better objective sleep quality

次要结局

  • Total score of Center for Epidemiological Study of Depression Scale(Immediately AND 6 months after the last session of the intervention)
  • Total score of Zarit Burden Interview(Immediately AND 6 months after the last session of the intervention)
  • Levels of inflammatory markers(Immediately AND 6 months after the last session of the intervention)
  • Total score of Revised Memory and Behavior Problem Checklist(Immediately AND 6 months after the last session of the intervention)
  • Total score of Quality of Life-Alzheimer's Disease Scale(Immediately AND 6 months after the last session of the intervention)
  • Patient-Reported Outcomes Measurement Information System (PROMIS) global health score(Immediately AND 6 months after the last session of the intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yeonsu Song, PhD, RN, FNP

Assistant Professor

University of California, Los Angeles

研究点 (6)

Loading locations...

相似试验